- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01683591
Dysphagia Assessment in Acute Ischemic Stroke Using High-resolution Manometry (DASH)
Dysphagia Screening in Acute Stroke Using High-resolution Impedance Manometry (DASH); Its Implication to Diet Decision and Clinical Outcome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The hypothesis tested in this study was that high-resolution manometry can provide the clinical efficacy to evaluate dysphagia and the diet plan in acute stroke patients. By using of stroke registry of our hospital, we assessed feasibility and usefulness of Dysphagia screening in Acute Stroke using High-resolution impedance manometry in patients with acute stroke.
The registry had the contents of two evaluation steps; the first step was the process to identify the patients with risk of possible aspiration and the second step was for detection of silent aspirators.
Firstly, the patient was interviewed regarding difficulties with food intake, chewing and swallowing, and the neurological signs were confirmed by two independent neurologists. After then, the patients were stratified into three aspiration risk group and controlled by proper diet program. Finally the emergence of aspiration pneumonia was observed.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 137-701
- Seoul St. Mary'S Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria: New stroke lesion should be present in MRI which compatible with clinical history and neurologic examination and patients with onset <= 48 hours.
Exclusion Criteria:
- hyperacute stroke receiving thrombolytic therapy
- symptom onset > 48 hours
- patients who died in the incipient stage of acute stroke
- neurological deterioration (increase in NIHSS ≥ 4)
- transient ischemic attack
- history of prior stroke and dysphagia
- other neurological diseases causing oropharyngeal dysphagia, such as Parkinsonism, dementia, and neuromuscular disorders
- history of cranial neurosurgery
- prior or current structural lesions causing oropharyngeal dysphagia,
- pulmonary diseases such as chronic obstructive pulmonary disease or current pneumonia.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
High-risk aspiration group
Among the consecutive stroke patients, categorized to high-risk group in the patient (1) was not on alert mentality (from drowsy to comatose mentality), (2) was not able to sit upright or control his/her head, and (3) failed to pass indirect water swallow test.
|
|
|
Low-risk aspiration group
Patents without oropharyngeal neurologic signs
|
|
|
Intermediate-risk aspiration group
If any one of following was positive, categorized to intermediate-risk group; (1) dysarthria, (2) motor aphasia, (3) inability to close and open lips or (4) facial weakness, (5) tongue deviation or (6) uvula deviation, (7) loss of gag reflex, and (8) inability to cough voluntarily.
|
The test was performed as general guideline for high-resolution impedance manometry test.
The parameter was obtained and analyzed using the Chicago classification for the liquid swallows with Takasaki's modification for pharyngeal function monitoring.
Swallowing pattern and aspiration risk were defined using real-time assessment of high-resolution impedance manometry test.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvement of diet program
Time Frame: Cases were followed for the duration of hospital stay, an average of 2 weeks.
|
All patients with dysphagia received swallowing rehabilitation training and were guided as per National Dysphagia Diet level or nasogastric tube feeding.
These patients were monitored in terms of the improvement of dietary program (e.g., From nasogastric tube feeding to step 4 dysphagia diet).
|
Cases were followed for the duration of hospital stay, an average of 2 weeks.
|
|
Occurrence of aspiration pneumonia
Time Frame: Cases were followed for the duration of hospital stay, an average of 2 weeks.
|
All patients were monitored in terms of development of aspiration pneumonia.
Aspiration pneumonia was defined as typical clinical signs (fever, sputum etc.) and chest radiographic findings (X-ray and computed tomography etc.).
|
Cases were followed for the duration of hospital stay, an average of 2 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall satisfaction measurement regarding program
Time Frame: 1 month after study enrollment
|
The patients also answered as visual analogue scales that measured their level of overall satisfaction regarding improvement of their symptoms with the protocol.
|
1 month after study enrollment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Joongseok Kim, MD, PhD, The Catholic University of Korea
Study record dates
Study Major Dates
Study Start
Primary Completion
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Gastrointestinal Diseases
- Pharyngeal Diseases
- Otorhinolaryngologic Diseases
- Esophageal Diseases
- Stroke
- Ischemic Stroke
- Ischemia
- Deglutition Disorders
Other Study ID Numbers
- 060613
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
University of CalgaryThe George Institute for Global Health, AustraliaRecruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation...RecruitingStroke | Stroke Gait Rehabilitation | Stroke Ischemic | Balance Deficits | Stroke (CVA) or Transient Ischemic AttackUnited States
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
University of MiamiNo longer availableStroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain AttackUnited States
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Jagiellonian UniversityCompletedStroke, Ischemic | Subacute StrokePoland
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Hyogo Medical UniversityRecruitingAcute Ischemic Stroke | Endovascular Therapy | Acute Ischemic Stroke (AIS) Related to a Distal OcclusionJapan
Clinical Trials on High-resolution impedance manometry test
-
Region Örebro CountyUnknownDysphagia | Oropharyngeal Dysphagia
-
Great Ormond Street Hospital for Children NHS Foundation...National Institute for Health Research, United KingdomRecruitingEsophageal Atresia With Tracheoesophageal FistulaUnited Kingdom
-
National Taiwan University HospitalCompletedEsophageal Motility DisordersTaiwan
-
Evangelic Hospital Kalk CologneCompletedAnxiety Disorders | GERD - Gastro-Esophageal Reflux DiseaseGermany
-
National Taiwan University HospitalNot yet recruitingthe Correlation Between the Barium Examination and High Resolution Impedance Manometry
-
University of LouisvilleWithdrawnChest Pain | Dysphagia | GERD | Achalasia | Post FundoplicationUnited States
-
IRCCS Policlinico S. DonatoUniversity of Pisa; Medical University of Vienna; Washington University School... and other collaboratorsCompleted
-
Hospices Civils de LyonCompleted
-
The Leeds Teaching Hospitals NHS TrustCompleted
-
University Hospital, RouenRecruiting